The Food and Drug Administration recently announced that, for the first time in more than 20 years, it will expand the range of permitted sunscreen options available to consumers this summer. This should increase competition, giving consumers more choices and lower prices. But you might be asking yourself: Why should I care? Cool, but is this really a big deal? It is because of what this decision says about the broader direction of the Trump administration and its FDA.
REFORM FDA ADVISORY COMMITTEES AND PUT RARE DISEASE PATIENTS FIRST
For years, the public became accustomed to a regulatory system that moved at a snail’s pace. New products, treatments, and technologies spent years working their way through bureaucratic processes before consumers could benefit.
The Trump administration is taking a different approach.
Time and time again, the administration pushed federal agencies to identify bottlenecks and speed up product approval when doing so can safely increase competition, innovation, and consumer choice.
